Narrative updates are currently in beta.

Back to narrative

European Expansion And Operational Improvements Will Unlock Cannabis Potential

WEED logo
WEED
AnalystConsensusTarget
Not Invested
Published 31 Mar 2025

Update shared on07 Aug 2025

Fair value Decreased 20%
Previous
AnalystConsensusTarget's Fair Value
CA$2.64
31.8% undervalued intrinsic discount
15 Aug
CA$1.80
Loading
1Y
-81.4%
7D
4.7%

Consensus analyst price targets for Canopy Growth have been revised lower primarily due to a marked slowdown in forecast revenue growth, resulting in a fair value decrease from CA$3.31 to CA$2.98.


What's in the News


  • Canopy Growth introduced its Canadian-grown 7ACRES brand in Australia, expanding its medical cannabis portfolio with high-THC sativa strains Ultra Jack and Jack Frost.
  • The company launched Deep Space Infused pre-rolls in Canada, featuring high-potency joints with THC levels above 60% to strengthen its position in infused formats.
  • Tom Stewart was appointed Interim CFO, succeeding Judy Hong, who played a key role in improving the company's capital structure and financial position.
  • Canopy Growth's auditor expressed doubt about the company's ability to continue as a going concern in its latest 10-K filing.
  • The company is expected to report Q1 2026 financial results on August 7, 2025.

Valuation Changes


Summary of Valuation Changes for Canopy Growth

  • The Consensus Analyst Price Target has fallen from CA$3.31 to CA$2.98.
  • The Consensus Revenue Growth forecasts for Canopy Growth has significantly fallen from 4.7% per annum to 3.2% per annum.
  • The Future P/E for Canopy Growth has fallen from 174.48x to 161.75x.

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.